Skip to main content
SpringerLink
Log in

A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A hypothalamic pathogenesis for the reduced GH secretion in aging has been reported for both animal and man. To further address this issue we studied in 31 elderly normal subjects (6 males and 25 females, aged 66–90 yr) and in 22 young healthy controls (13 males and 9 females, aged 20–35 yr) the GH responses to GHRH test (GHRH29, 1 μg/kg iv as a bolus at 0 min) alone and combined with pyridostigmine, a cholinesterase inhibitor (PD, 120 mg po 60 min before GHRH), or with arginine (ARG, 30 g in 100 ml infused from 0 to 30 min). Serum IGF-I levels were lower in elderly than in young subjects (mean±SE: 86.9±7.2 vs 288.7±22.1 μg/L, p<0.01). The GHRH-induced GH increase was lower in elderly than in young subjects (p<0.01). PD increased the GH response to GHRH in both groups (p<0.001), but in elderly subjects this response persisted lower (p<0.0001) than that ob-served in young adults. Also ARG coadministration potentiated the GHRH-induced GH release in both groups (p<0.0001) but in this case the elderly’s responses overlapped with the young’s. The GH in-crease observed after combined administration of ARG and GHRH was higher (p<0.0001) than that elicited by PD plus GHRH in elderly but not in young subjects. Analyzing individual GH responses, a GH peak below the limit of normality for young adults was observed in 19 (61.3%) elderly subjects after PD plus GHRH administration while ARG plus GHRH test elicited a normal GH peak in all but one. Taking into account that the GH-releasing effect of both PD and ARG is likely mediated by inhibition of hypothalamic somatostatin release, our data show that in elderly subjects the acutely releasable GH pool is preserved and give support to the hypothesis that a somatostatin hypertone underlies the reduced GH secretion of aged individuals. PD but not ARG fails to potentiate the GH response to GHRH in about 60% of aged subjects. These findings are suggestive for an impairment of the hypothalamic cholinergic system which, in turn, would be responsible for somatostatin hyperactivity and GH hyposecretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rudman D., Kutner M.H., Rogers M., Lubin M.F., Fleming G.A., Bain R.P. Impaired growth hormone secretion in the adult population. J. Clin. Invest. 67:1361, 1981.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  2. Zadik Z., Chalew S.A., McCarter R.J., Meistas M., Kowarski A.A. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 60:513, 1985.

    Article  PubMed  CAS  Google Scholar 

  3. Rudman D., Feller A.G., Nagraj H.S. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323:1, 1990.

    Article  PubMed  CAS  Google Scholar 

  4. Shibasaki T., Shizume K., Nakahara M. Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. J. Clin. Endocrinol. Metab. 53:212, 1984.

    Article  Google Scholar 

  5. lovino M., Monteleone P., Steardo L. Repetitive growth hormone-releasing hormone ad-ministration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging. J. Clin. Endocrinol. Metab. 69:910, 1989.

    Article  Google Scholar 

  6. Ghigo E., Goffi S., Arvat E., Nicolosi M., Procopio M., Bellone J., Imperiale E., Mazza E., Baracchi G., Camanni F. Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging. Acta Endocrinol. (Copenh.) 123:169, 1990.

    CAS  Google Scholar 

  7. Ghigo E., Goffi S., Nicolosi M., Arvat E., Procopio M., Bellone J., Mazza E., Camanni F. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab. 71:1481, 1990.

    Article  PubMed  CAS  Google Scholar 

  8. Alba-Roth J., Albrecht A., Muller O., Schopol J., Von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Edocrinol. Metab. 67:1186, 1988.

    Article  CAS  Google Scholar 

  9. Casanueva F.F., Villanueva C., Dieguez J. Atropine blockade of growth hormone(GH)-releas-ing hormone-induced GH secretion in man is not exerted at pituitary level. J. Clin. Endocrinol. Metab. 62:186, 1986.

    Article  PubMed  CAS  Google Scholar 

  10. Ghigo E., Bellone J., Mazza E., Imperiale E., Procopio M., Valente F., Lala R., De Sanctis C, Camanni F. Arginine potentiates the GHRH- but not the pyri-dostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin. Endocrinol. (Oxf.) 32:763, 1990.

    Article  CAS  Google Scholar 

  11. Locatelli V., Torsello A., Redaelli M., Ghigo E., Massara F., Muller E.E. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation of somatostatin. J. Endocrinol. 11:271, 1986.

    Article  Google Scholar 

  12. Massara F., Ghigo E., Molinatti P., Mazza E., Locatelli V., Camanni F. Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. Acta Endocrinol. (Copenh.) 113:12, 1986.

    CAS  Google Scholar 

  13. Page M.D., Dieguez C., Valcavi R., Edwards C, Hall R., Scanlon M.F. Growth hormone (GH) responses to arginine and I-dopa alone and after GHRH pretreatment. Clin. Endocrinol.(Oxf.) 23:551, 1988.

    Article  Google Scholar 

  14. Richardson S.B., Hollander C.S., D’Eletto R., Greenhfaf F., Thaw C. Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro. Endocrinology 707:1837, 1980.

    Google Scholar 

  15. Ross R.J.M., Tsagarakis S., Grossman A., Nhagafoong L, Besser G.M. GH feedback occurs through modulation of hy-pothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH. Clin. Endocrinol. (Oxf.) 27:727, 1987.

    Article  CAS  Google Scholar 

  16. Torsello A., Panzeri G., Cermenati P., Ghigo E., Camanni F., Muller E.E., Locatelli V. Involvement of somatostatin and cholinergic system in the mechanism of growth hormone autofeedback regulation in the rat. J. Endocrinol. 117:273, 1988.

    Article  PubMed  CAS  Google Scholar 

  17. Arce V., Cella S.G., Loche S., Ghigo E., Devesa J., Muller E.E. Synergistic effect of growth hormone-releasing hormone (GHRH) and clonidine in stimulating GH release in young and old dogs. Brain Res., in press.

  18. Forman L.J., Sonntag W.E., Hylka V.W., Meites J. Pituitary growth hormone and hypothalamic so matostatin in young female rats versus old constant estrous female rats. Experiential: 653, 1985.

  19. Ge F., Tsagarakis S., Rees L.H., Besser G.M., Grossman A. Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in vitro release from hypothalamic explants. J. Endocrinol. 123:53, 1989.

    Article  PubMed  CAS  Google Scholar 

  20. Locatelli V., Cella S.G., Cermenati P., Panzeri G., Sellan R., Muller E.E. Defective growth hormone (GH) secretion in aging mammals: contribution of central and peripheral inhibitory influences and of GH-releasing hormone. In: Valenti G. (Ed.), Psychoneuroendocrinology of aging: basic and clinical aspects. Fidia Research Series, Liviana Press, Padova, vol. 16, P.61, 1989.

    Google Scholar 

  21. Panzeri G., Torsello A., Cella S.G., Muller E.E., Locatelli V. Age-related modulatory activity by a cholinergic agonist on the growth hormone response to GH-releasing hormone in the rat. P.S.E.B.M. 793:301, 1990.

    Google Scholar 

  22. Sonntag W.E., Forman L.J., Miki N. Effects of CNS active drugs and somatostatin anti-serum on growth hormone release in young and old male rats. Neuroendocrinology 33:73, 1981.

    Article  PubMed  Google Scholar 

  23. Sonntag W.E., Gottschall P.E., Meites J. Increased secretion of somatostatin-28 from hy pothalamic neurons of aged rats in vitro. Brain Res. 380:229, 1986.

    Article  PubMed  CAS  Google Scholar 

  24. Spik K., Sonntag W.E. Increased pituitary response to somatostatin in aging male rats: relationship to somatostatin receptor number and affinity. Neuroendocrinology 50:489, 1989.

    Article  PubMed  CAS  Google Scholar 

  25. Ceda G.P., Valenti G., Butturini U., Hoffmann A.R. Diminished pituitary responsiveness to growth hormone-releasing factor in aging male rats. Endocrinology 71 2109, 1986.

    Article  Google Scholar 

  26. Robberecht P., Gillard M., Waelbroeck M., Camus J.C., De Neef P., Christophe J. Decreased stimulation of adenylate cyclase by a growth hormone releasing factor in the anterior pituitary of old rats. Neuroendocrinology 44:429, 1986.

    Article  PubMed  CAS  Google Scholar 

  27. Sonntag W.E., Hylka V.W., Meites J. Impaired ability of old male rats to secrete growth hormone in vivo but not in vitro in response to hpGRF-(1–44). Endocrinology 7 73:2305, 1983.

    Article  Google Scholar 

  28. Wehrenberg W.B., Ling N. The absence of an age-related change in the pitu-itary response to growth hormone-releasing factor in rats. Neuroendocrinology 37:463, 1983.

    Article  PubMed  CAS  Google Scholar 

  29. Yu-Kai-Sun Y.P., Fenoglio CM., Pushparaj N. The effect of age on the number of pituitary cells im-munoreactive to growth hormone and prolactin. Human Path. 15:169, 1984.

    Article  Google Scholar 

  30. Cella S.G., Moiraghi V., Minuto F. Prolonged fasting or clonidine can restore the de-fective growth hormone secretion in old dogs. Acta Endocrinol. (Copenh.) 12:177, 1989.

    Google Scholar 

  31. De Gennaro Colonna V., Zoli M., Cocchi D. Reduced growth hormone releasing factor (GHRH- like immunoreactivity and GHRH gene expression, in hypothalamus of aged rats. Peptides 47:459, 1989.

    Google Scholar 

  32. Morimoto N., Kawakami F., Makino S., Chihara K., Hasegawa M., Ibata Y. Age-related changes in growth hormone releasing factor and somatostatin in the rat hypothalamus. Neuroendocrinology 47: 459, 1988.

    Article  PubMed  CAS  Google Scholar 

  33. Delltala G., Frulio T., Pacifico A., Maioli M. Participation of cholinergic muscarinic receptors in glucagon and arginine mediated growth hormone secretion in man. J. Clin. Endocrinol. Metab. 55:1231, 1982.

    Article  Google Scholar 

  34. Raskind M.A., Peskind E.R., Verth R.C., Wilkinson C.W., Federighi D., Dorsa D.M. Differential effects of aging on neuroendocrine re-sponses to physostigmine in normal men. J. Clin. Endocrinol. Metab. 70:1420, 1990.

    Article  PubMed  CAS  Google Scholar 

  35. Lucey J.V., O’Keane V., O’Flynn K., Clare W.A., Dinar T.G. Gender and age differences in the growth hormone response to pyridostigmine. Int. Clin. Psychopharmacol. 2:105, 1991.

    Article  Google Scholar 

  36. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408, 1988.

    Article  Google Scholar 

  37. Gibson G.E., Peterson C, Jender D.J. Brain acetylcholine synthesis declines with senes-cence. Science 213:675, 1981.

    Article  Google Scholar 

  38. White P., Hiley C.R., Goodhardt M.J. Neocortical cholinergic neurons in elderly people. Lancet 7:668. 977.

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Fisiopatologia Clinica, Divisione di Endocrinologia, Universita di Torino, Milano, Italy

    E. Ghigo, S. Goffi, E. Arvat, E. Imperiale, G. M. Boffano, M. R. Valetto, E. Mazza, A. Magliona, M. F. Boghen, G. Boccuzzi &  F. Camanni

  2. Ospedale Trivulzio, Milano, Italy

    I. Santi

Authors
  1. E. Ghigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Goffi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Arvat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Imperiale
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. M. Boffano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. R. Valetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Mazza
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. I. Santi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Magliona
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. F. Boghen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. G. Boccuzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. F. Camanni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghigo, E., Goffi, S., Arvat, E. et al. A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging. J Endocrinol Invest 15, 665–670 (1992). https://doi.org/10.1007/BF03345812

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345812

Keywords

Search

Navigation